Split History
ETFs Holding HTBX »    HTBX Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Heat Biologics is a biopharmaceutical company developing immunotherapies focused on activating a patient's immune system against cancer through T-cell activation and expansion. Co.'s T-cell Activation Platform, includes two variations for intradermal administration, Immune Pan-antigen Cytotoxic Therapy and Combination Pan-antigen Cytotoxic Therapy. To further augment antigen experienced T-cell activation and expansion, Co. is also developing a T-cell co-stimulator PTX-35 for systemic administration. These programs are designed to harness the body's natural antigen specific immune activation and tolerance mechanisms to reprogram immunity and provide a long-term clinical effect. According to our HTBX split history records, Heat Biologics has had 1 split.
HTBX split history picture
Heat Biologics (HTBX) has 1 split in our HTBX split history database. The split for HTBX took place on January 22, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of HTBX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as Heat Biologics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the HTBX split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Heat Biologics shares, starting with a $10,000 purchase of HTBX, presented on a split-history-adjusted basis factoring in the complete HTBX split history. HTBX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/24/2013
End date: 07/06/2020
Start price/share: $95.70
End price/share: $0.84
Dividends collected/share: $0.00
Total return: -99.12%
Average Annual Total Return: -49.38%
Starting investment: $10,000.00
Ending investment: $87.74
Years: 6.96
Date Ratio
01/22/20181 for 10
HTBX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

IART Split History
IBIO Split History
ICAD Split History
ICCC Split History
ICLR Split History
ICUI Split History
IDRA Split History
IDXG Split History
IDXX Split History
IGC Split History

Also explore: HTBX shares outstanding history

Altus Midstream Company (ATLM)
FS KKR Capital Corp. (FSK)
Groupon (GRPN)
XpresSpa Group, Inc. (XSPA)
Energy Focus, Inc. (EFOI)
The Cushing NextGen Infrastructure Income Fund (SZC)
Teligent, Inc. (TLGT)
Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

HTBX Insider Buying

HTBX Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.